Joint Formulary & PAD

Terbutaline (Bricanyl Turbohaler) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Terbutaline (Bricanyl Turbohaler)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
SABA
Keywords :
SABAs, bronchodilators, adrenoreceptor agonists, short acting beta 2 agonist, respiratory
Brand Names Include :
Bricanyl Turbohaler
Important Information :

Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
3

Other Indications

Below are listed other indications that Terbutaline (Bricanyl Turbohaler) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

Bricanyl Turbohaler is not a locally preferred device.

The locally preferred SABA devices are as follows:

Low carbon:

  • Salbutamol Easyhaler (dry powder inhaler)
  • Ventolin Accuhaler (dry powder inhaler)

Alternative devices:

  • Salamol (MDI) is the locally preferred salbutamol metered dose inhaler device and should be used with a spacer device. It has a lower carbon footprint than the large volume MDIs such as Ventolin.
  • Ventolin Evohaler (MDI) 

Branded prescribing of inhaler devices is recommended.

See COPD local guidelines for more information